Craft Spirits to Dominate Global Spirit Market: Ken Research

Ken Research has announced publication titled, “Opportunities in Craft Spirits” which explores the top trends and innovation themes within the craft spirits industry.
The report is a requisite guide that covers the present scenario and further provides for the growth prospects of the craft beer market in the years to come. It evaluates the current and future growth occasions across regions and countries with the motive of supporting corporate development and related initiatives.

It helps in gaining a broader appreciation of the fast-moving consumer goods industry by gaining insights from within as well as outside. It gets easier to access valuable strategic take-outs that help in directing future decision-making and informing about new products development.
The preferences of beer consumers have changed due to the introduction of craft beers, which typically contains higher alcohol content. Tracking the success of craft beers over the past few decades, the spirits industry is commencing to take hold of the craft movement.
Trustworthy experiences are in demand and more consumers are looking to experiment with innovative and strange flavored spirits. As a result, a number of distillers are expected to raise their craft offerings to gain an early foothold in the emerging market.
In 2003, there were 60 craft distillers operating in the United States. Today, that total is 760, according to the American Distilling Institute (ADI), and a further 200 are under construction. There are numerous opportunities within the craft spirits market and they are expected to bring innovation themes such as the incorporation of innovative and/or medicinal ingredients.
Some recent mergers and acquisitions are pledging to continue changing the industry. In 2015, Mahalo Spirits Group invested in Bardstown Bourbon Co. of Kentucky, financing a USD 25 million distillery and Angels Envy Bourbon sold itself to Bacardi for USD 150 million. Hood Rivers Distillers of Oregon acquired Seattle’s Big Gin last May, and Constellation Brands acquired High West Distillers of Park City, Utah in 2016.
Most recently, Davos Brands of New York acquired Aviation Gin of Portland, Ore., and Remy Cointreau of France obtained Seattle’s Westland Distillery.

Topics Covered in The Report

• Global beer industry research report
• Global Beer industry insights
• Global Alcoholic beverages Industry
• Global Alcohol Consumption by volume
• North America Alcohol Industry Research Report
• Europe Alcoholic Beverages Market size
• Aisa Alcoholic Beverages industry research
• Global spirits market research
• Craft Spirits Demand worldwide
• Global Craft Spirits future Outlook

For more coverage click on the link below:
https://www.kenresearch.com/food-beverage-and-tobacco/alcoholic-beverages/opportunities-craft-spirits/78857-11.html
Related links:
https://www.kenresearch.com/food-beverage-and-tobacco/alcoholic-beverages/global-beer-trends-2016/73697-11.html
https://www.kenresearch.com/food-beverage-and-tobacco/alcoholic-beverages/beer-market-asia-2019/1432-11.html
Contact:
Ken Research
Ankur Gupta,
Head Marketing & Communications
query@kenresearch.com
+91-124- 4230204

Mexican Magic-The wave of Ice Cream catching up, Market Research Report: Ken Research

Ken research announced recent publication on, "Consumer and Market Insights: Ice Cream in Mexico". This market insights report focuses on the Ice Cream market in Mexico. It sheds light on the ingredient materials, types and closures category level distribution and brands market shares prevailing in this economy. We analyse the overall market value and volume data with growth analysis for 2010-2020. Value and growth analysis for Artisanal Ice Cream, Impulse Ice Cream-Single Serve, and Take-Home and Bulk Ice Cream with inputs on individual segment share within each category and the change in their market share forecast for 2015-2020. Leading player's market share of various brands and private labels followed by private label growth analysis during 2012-2015 is viewed. The percentage of sales within each category through distribution channels such as Hypermarkets & Supermarkets, Convenience Stores, Food & Drinks Specialists, On-trade and others is provided followed by the packaging data analysis, which compasses consumption breakdown for packaging materials and containers in each category, in terms of percentage share of number of units sold. Packaging material data for Flexible Packaging, Paper & Board and Rigid Plastics; container data for: Bag/Sachet, Tub and Wrapper etc. are given due importance. Clients can very well identify elevated potential categories and explore further market opportunities based on detailed value and volume analysis. Gaining an understanding of the total competitive landscape based on detailed brand share analysis to plan effective market positioning is this reports key function.

LATEST TRENDS AND SYNOPSIS
Mounting economy and a large base of youthful population is driving the Ice Cream market in Mexico. The market is led by the 'Take-Home and Bulk Ice Cream' category in both Off-trade and On-trade volume consumption. Hypermarkets & Supermarkets account for the highest allocation share of Ice Cream in the country. Unilever Plc, Nestle S.A. and General Mills, Inc. are the leading players in the Mexican Ice Cream market.
The Ice Cream market in Mexico is forecasted to grow at a CAGR of 2.9% in US$ terms during 2015-2020. Mexican consumers are opting for value for money products in the Ice Cream market. The 'Take-Home and Bulk Ice Cream' category accounts for the highest Off-trade & On-trade volume consumption in Mexico. On-trade sales account for the highest distribution share in 'Take-Home and Bulk Ice Cream' and Artisanal Ice Cream categories. Holanda is the leading brand in 'Take-Home and Bulk Ice Cream' and 'Impulse Ice Cream-Single Serve' categories in Mexico. Flexible Packaging is the most commonly used packaging material in the Mexican Ice Cream market. In 2016, sales of ice cream were driven by the consolidation of modern retailers, which included the dynamic growth of convenience stores in the country. It sometimes seems that every time you look around there is a new ice cream parlour or store offering the latest in exotic flavours. The propagation of fancy brands such as Haagen Dazs, Ben and Jerry’s, Santa Clara contributes well to this mesmerizing ice cream market.
Also somewhat surprising, for a relatively low-wage country, is the amount of business done by ice cream brands of which a single serving cone or tub can cost anything from three to four US dollars.
Modern retailers are better equipped with freezers and have more attractive displays of frozen products, which allow a wider range of options and a significant increase in the availability of frozen products. In 2016, the number of convenience stores increased, compared with the previous year, while supermarkets and hypermarkets maintained positive growth in terms of outlets. Hollanda was followed by Grupo Herdez SAB de CV. These companies have a strong presence in the country with wide distribution networks, which means their products and freezers are present in almost every independent small grocer, as well as almost every convenience store. In 2016, both companies are expected to remain leaders in the category. Over the forecast period, sales of ice cream are expected to grow as consumers try new flavours and formats. Also over the forecast period, stronger competition might be observed as Grupo Herdez positions the recently acquired brands from Nestlé and as Nestlé positions the relaunched brand Danesa 33. In 2021, sales of ice cream and frozen desserts are set to reach Mx$10.0 billion at constant 2016 prices.
A positive impact of the current weather conditions of harsh summers across Mexico is improving. In addition, the drought is easing in some areas. Therefore, some dairy operators anticipate more water availability during Q2 and Q3. Pacific Northwest milk production is steady and following normal seasonal patterns. A few bouts of wet weather have kept a lid on milk production, but output has quickly returned as the temperatures moderate. Processors report milk intakes are well balanced with manufacturing needs. Bottling demand is steady and has returned to pre-holiday levels. Industry contacts expect milk volumes to recover as warmer temperatures build into the region. While weather events are suppressing production, manufacturers report there seems to be no shortage of milk available for processing. Contacts further report farmers are already making plans to expand or start new dairies in the coming months. The additional cows and already strong milk intakes are prompting some milk handlers to think about how best to balance the milk supply once the region enters into spring flush.
Topics Covered in The Report

• Mexico Ice cream market Research Report
• Ice cream market Mexico
• Mexico ice cream market Future Outlook
• Mexico ice cream market trends
• Ice cream market major players mexico
• Mexico Ice cream market size
• Mexico Ice cream market trends
• Mexico Ice cream market growth
• Mexico Ice cream market future
• Mexico Ice cream market share
• Mexico Ice cream market analysis

For more coverage click on the link below:
https://www.kenresearch.com/food-beverage-and-tobacco/dairy-products/consumer-insights-ice-cream-mexico/78840-11.html
Related links:
Consumer and Market Insights: Ice Cream in Chile
Canadean
 Consumer and Market Insights: Ice Cream in Denmark 
Canadean
 Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
query@kenresearch.com
+91-124-4230204

The UAE UPS Market is Dominated by APC by Schneider Electric, Vertiv/Emerson Network Power and Eaton : Ken Research

UAE UPS market  has been witnessing considerable year on year growth over the past decade as the number of small and medium businesses (SMB’s) and other commercial establishments have continuously risen during the period. Moreover, the data center market of the country has also enhanced; providing a significant boost to the industry over the period 2011-2016.
Expansion of Jebel Ali Zone in 2014, amplified the demand for UPS systems in Dubai in the subsequent year (2015) as several new businesses and companies were set up. Completion of several other major commercial projects also supported growth in the market over the period 2015-2016. UPS market further experienced high growth in year 2016 with more than 22,000 small businesses established in Dubai during the year.

Line Interactive is the most popular UPS type in the UAE due to high reliability, ideal making for rack/distributed servers and for harsh power environments. These types of UPS systems are demanded by majority of commercial establishments in the UAE, especially SMB’s due to which it has gathered the largest share in the market.
Online systems are slightly more expensive compared to line interactive systems. Furthermore, line Interactive UPS systems provide better reliability and similar conditioning at a better value. More importantly, majority of them are manufactured with a KVA rating of above 10 which are considerably popular amongst the SMB’s in the UAE.
Majority of SME’s in the UAE use UPS systems with KVA rating below 10. This has been the main reason behind the dominance of below 10 KVA UPS systems in the UAE. Apart from this, retails shops, malls, schools, colleges and residential sector also demand UPS of below 10 KVA. Above 100 KVA UPS systems are used only for specific projects. Generally very large organizations with 1,000 + employees and data centers demand for UPS systems above 100 KVA.
Apart from this, the growing IT market of UAE which demand technologically advanced high cost UPS will also supplement the growth in the industry over the period 2017-2021.
For more information on the market research report please refer to the below link:
https://www.kenresearch.com/energy-and-utilities/power/uae-ups-market-report/80396-103.html
 Topics Covered in the Report

• Emerson Network Power Performance UPS
• Tripp Lite Competition UPS,
• Future Growth UPS Market,
• UAE UPS Market
• UAE UPS Market Size
• UAE Online UPS Market

Related Reports
India Solar Inverter Market Outlook to 2020 - Continuous Government Support and Advent of Micro Solar Inverter to Foster Future Growth
Hinduja-India Solar Power Stations Program 1000 Mw-India-Construction Project Profile

NLC-Southern India Solar Power Plant Program 4000 Mw-India-Construction Project Profile

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

India Pediatric Drugs and Vaccines Market Outlook to 2021 : Ken Research

Ken Research Latest report on  “India Pediatric Drugs and Vaccines Market Outlook to 2021– Rise in prevalence of chronic diseases and inclusion of several new vaccines in national immunization programme to Shape Future Growth” provides a comprehensive analysis of the pediatric drugs and vaccines market in India and covers market size and segmentation of overall market by drugs and vaccines. The report covers the further segmentations of different spaces such as Drugs and Vaccines into sub segments based on their individual characteristics. The sub segments of Drugs (Patented and Generic, Treatment and Management, Drug Classes, Prescription and OTC, Online and Offline) are then considered separately and analysis on them has been done individually. Similarly, the sub segments of Vaccines (Monovalent and Multivalent, Technology, Indication) have also been considered. The report covers detailed profiles of leading players in the different sub segments in the market. The potential and future outlook has been individually discussed for India Pediatric Drug and Vaccine market. The report provides detailed analysis of segments, trends & developments, growth drivers and major restraints and challenges within the industry. The report also serves as a benchmark for existing players and for new players who wish to capitalize on the market potential and investors who are looking forward to venture into pediatric drugs and vaccines market in India.

India Pediatric Drugs Market
India is a home of the largest pediatric population of the world and also has the highest number of annual child births in the world. However, almost ~% of the medicines used in children presently has never been studied for their efficacy in pediatric population. The pediatric drugs market in India grew at a staggering CAGR of ~% during the period FY’2011-FY’2016 exhibiting the annual revenue of INR ~ billion in FY’2011 which inclined to INR ~ billion in FY’2016. Owing to an astounding number of births in the country, the pediatric drugs market has showcased growth at a faster pace than the overall pharmaceutical market of the country during the concerned period.
Segmentation
By Product Type (Patented and Generic): The market for pediatric drugs and vaccines in India is entirely driven by companies manufacturing generic drug formulations. Almost all pharmaceutical companies operating in the country have expertise in developing generic drugs so as to cater to the underprivileged population at a much cheaper price. Generic drug therefore comprised almost ~% of the market share as of FY’2016 whereas patented drugs accounted for ~% market share.
By Usage (Treatment and Management): A large part of drugs sold in the country is meant for the treatment of several infectious and non-infectious diseases prevalent in the pediatric population. Pediatric drugs are most commonly used for diarrheal diseases such as cholera and viral gastroenteritis. Owing to less prevalence of lifestyle diseases amongst pediatric population, market share of drugs meant for management of diseases has been low. Drugs meant for management of diseases accounted for ~% market share as compared to ~% for treatment of diseases.
By Drug Classes (Anti-Infectives, Antihistamines, Cardiovascular Drugs and Others): Anti-infectives were the most frequently prescribed drug class by pediatricians, with over ~% of the prescriptions had some form of prescribed antibiotics. This was due to wide scale prevalence of respiratory diseases among children. Anti-infectives accounted for a market share of ~% as of FY’2016 as compared to anti-histamines (~%), cardiovascular drugs (~%) and all other (~%) categories of drugs.
By Procurement Method (Prescription and OTC): In India, parents always consult a doctor for their children’s illness and therefore only buy drugs that are prescribed by a healthcare professional. Scenario is same in both rural and urban areas as parents are very conscious about children’s well being and are not willing to rely on OTC drugs without proper knowledge and supervision. Prescription drugs therefore contributed to around ~% in market share as compared to ~% by OTC drug as of FY’2016.
By Distribution Channel (Online and Offline): Currently, procurement of pediatric drugs is almost entirely done through offline medium from hospital pharmacies, retail pharmacies, doctors or institutional health centers. Since the requirement of drugs is usually on an urgent basis, parents don’t prefer placing an order online and receive it a later date. As a result, offline sales of drugs accounted for almost ~% of the drug sales as compared to ~% by online medium.
India Pediatric Vaccines Market
India has emerged as the leading vaccine producer in the world, in terms of doses of vaccines produced. The country has ~ major vaccine manufacturing facilities across the country as of FY’2016. Vaccines manufactured in these facilities are offered in both national and international market (over 150 countries). More than ~% of all measles vaccines used globally are produced in India.
The Indian pediatric market for vaccines has grown at a remarkable CAGR of ~% during the period FY’2011-FY’2016. The growth was attributed to some crucial vaccines (polio, hepatitis B, MMR and BCG) manufactured by Indian companies constantly featured in WHO’s prequalified list coupled with the fact that Indian companies (Serum Institute of India, Bharat Biotech, Panacea Biotec) acted as major suppliers of vaccines to WHO, UNICEF, PATH and other UN agencies. The market for pediatric vaccines grew from INR ~ billion in FY’2011 to INR ~ billion in FY’2016.
Segmentation
By Type of Vaccine A large chunk of vaccines administered under the national immunization programme in the country are of the monovalent form. Monovalent vaccines therefore comprised for a market share of ~% as compared to ~% by multivalent forms.
By Technology: Inactivated vaccines were the earliest forms of vaccines developed by scientists and continue to be widely used in the country. Killed or inactivated vaccine comprised a market share of ~% as compared to ~% by live or attenuated, ~% by toxoid vaccines, ~% by subunit forms, ~% by conjugate vaccines and remaining ~% by all other forms.
Key Topics Covered in the Report:

• Value Chain Analysis of India Pediatric Drugs and Vaccine Market
• India Pediatric Drugs and Vaccine Market by Value, FY’2011-FY’2016
• India Pediatric Drugs Market Introduction and Size, FY’2011-FY’2016
• India Pediatric Drugs Market Segmentation by Product Type (Patented and Generic), by Usage (Treatment and Management), by Drug Classes (Anti-infectives, Antihistamines, Cardiovascular drugs and Others), by Procurement Method (Prescription and OTC), by Distribution Channel (Offline and Online), FY’2016
• Competitive Landscape of Major Players in India Pediatric Drugs Market
• India Pediatric Drugs Future Market Outlook, FY’2017-FY’2021
• India Pediatric Vaccines Market introduction and Size, FY’2011-FY’2016
• India Pediatric Vaccines Market Segmentation by Vaccine Type (Monovalent and Multivalent), by Technology (Live or attenuated, Killed or inactivated, Toxoid, Conjugate, Subunit and Others), by Indication (Polio, MMR, DTP, Hepatitis B, Influenza, BCG and Others), FY’2016
• Competitive Landscape of Major Players in India Pediatric Vaccines Market
• Pipeline Analysis of Global and India Pediatric Vaccine Market
• India Pediatric Vaccines Future Market Outlook, FY’2017-FY’2021

• Vaccines Market Growth India
• Drug Information Dosage Side Effects,
• Pediatric Vaccine Serum Institute of India
• New Drug Launches India Pharma Sector
• Number of Pediatrician  Statistics
• Pediatric tuberculosis drug Market
• Drug Pipeline Pediatric Drug,
• Vaccine Clinical Trials India

For more information about the publication, refer to below link:
https://www.kenresearch.com/healthcare/pharmaceuticals/india-pediatric-drug-vaccine-market/81319-91.html
Related Reports:
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market

US Aesthetic Lasers and Energy Devices Market Outlook to 2020 - Aging Population and High Prevalence Rate of Obesity to Foster Future Growth
Qatar Wellness Market Outlook to 2020 - Rising Awareness about health & Fitness and Prevalence in Lifestyle Diseases will drive the Market
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

India pediatric drugs and vaccines market has been largely driven by the launch of new drug categories such as Anti-TB drugs and improved healthcare access: Ken Research

• India’s emergence as a global hub of generic medicines and vaccine supplier has contributed highly towards the growth of the pediatric drugs and vaccines market.
• The pediatric market for drugs and vaccines has increased in terms of value from FY’2011 to FY’2016 at a CAGR of 18.1% in between the period.

Ken Research announced its latest publication on “India Pediatric Drugs and Vaccines Market – Rise in prevalence of chronic diseases and inclusion of several new vaccines in national immunization programme to Shape Future Growth” which provides a comprehensive analysis of the pediatric drugs and vaccines market in India and covers market size and segmentation of overall market by drugs and vaccines. The report covers the further segmentations of different spaces such as Drugs and Vaccines into sub segments based on their individual characteristics. The sub segments of drugs (Patented and Generic, Treatment and Management, By Drug Classes, Prescription and OTC, Online and Offline) are then considered separately and analysis on them has been done individually. Similarly, the sub segments of vaccines (Monovalent and Multivalent, By Technology, and By Indication) have also been considered and market analysis on these entire segments is explained in detail in the study. The report also covers detailed profiles of leading players in the different sub segments in the market. The potential and future outlook has been individually discussed for India Pediatric Drugs and Vaccines market. The report provides detailed analysis of segments, trends & developments, growth drivers and major restraints and challenges within the industry. The report also serves as a benchmark for existing players and for new players who wish to capitalize on the market potential and investors who are looking forward to venture into pediatric drugs and vaccines market in India.
Almost all pharmaceutical companies operating in the country had expertise in developing generic drugs so as to cater to the underprivileged populations at a much cheaper price. Generic drug therefore comprised a vast majority of the market share as of FY’2016 as compared to patented drugs.
India has a huge disease burden and a large part of drugs sold in the country was meant for the treatment of several infectious and non-infectious diseases prevalent in the pediatric population. Pediatric drugs were most commonly used for diarrheal diseases such as cholera and viral gastroenteritis. Respiratory diseases including pneumonia and tuberculosis were other commonly treatable conditions for which drugs found extensive usage in the country. Drugs sold for purpose of treatment of diseases accounted for maximum market share as of FY’2016. Owing to less prevalence of lifestyle diseases amongst pediatric population, market share of drugs meant for management of diseases has been low. Drugs meant for management of diseases were typically chronic diseases, particularly degenerative non-communicable diseases (NCDs) such as chronic respiratory diseases, cardiovascular diseases, cancer, HIV/AIDS and diabetes amongst others.
Anti-infectives were the most frequently prescribed drug class by pediatricians, with over 80% of the prescriptions had some form of prescribed antibiotics. This was due to wide scale prevalence of respiratory diseases among children. Anti-infectives accounted for the largest market share as of FY’2016 as compared to anti-histamines, cardiovascular drugs and all other categories of drugs.
The market for pediatric drugs and vaccines was largely driven by drug manufacturing companies, owing to availability of large portfolio of drugs for treatment of several diseases as compared to a limited number of vaccines for prevention of some infectious diseases. High efficacy of vaccines has ensured prevention against diseases by virtue of few doses of vaccines. On the other hand, repeated incidence of some or the other non-vaccine preventable medical conditions coupled with comparatively heavy requirement of drug doses have resulted in a far greater usage of drugs. Sun Pharmaceuticals, Lupin Pharmaceuticals, Cipla, Dr. Reddy’s Laboratories and Abbott were some of the major companies operating in the drug space amongst others. Some of the leading vaccine manufacturers included Serum Institute of India, Panace Biotec, Bharat Biotech, GSK India and Biological E Limited amongst others.
“Strong government support to transform India into a global leader in end-to-end manufacturing, expected rise in sale of flavored TB and antiretroviral drugs and increasing prevalence of diabetes and asthma in pediatric population are the major factors which are expected to drive the growth of India pediatric drugs and vaccines market in future. With promising growth prospects, the industry has created numerous opportunities for every stakeholder in the pharmaceutical ecosystem.”, according to the Research Analyst, Ken Research.
Key Topics Covered in the Report:

• Value Chain Analysis of India Pediatric Drugs and Vaccine Market
• India Pediatric Drugs and Vaccine Market by Value, FY’2011-FY’2016
• India Pediatric Drugs Market Introduction and Size, FY’2011-FY’2016
• India Pediatric Drugs Market Segmentation By Product Type (Patented and Generic), by Usage (Treatment and Management), by Drug Classes (Anti-infectives, Antihistamines, Cardiovascular drugs and Others), by Procurement Method (Prescription and OTC), by Distribution Channel (Offline and Online), FY’2016
• Competitive Landscape of Major Players in India Pediatric Drugs Market
• India Pediatric Drugs Future Market Outlook, FY’2017-FY’2021
• India Pediatric Vaccines Market introduction and Size, FY’2011-FY’2016
• India Pediatric Vaccines Market Segmentation by Vaccine Type (Monovalent and Multivalent), by Technology (Live or attenuated, Killed or inactivated, Toxoid, Conjugate, Subunit and Others), by Indication (Polio, MMR, DTP, Hepatitis B, Influenza, BCG and Others), FY’2016
• Competitive Landscape of Major Players in India Pediatric Vaccines Market
• Pipeline Analysis of Global and India Pediatric Vaccine Market
• India Pediatric Vaccines Future Market Outlook, FY’2017-FY’2021
• Porter Five Forces Analysis in India Pediatric Drugs and Vaccines Market
• Issues and Challenges in India Pediatric Drugs and Vaccines Market
• Government Regulations in India Pediatric Drugs and Vaccines Market
• Analyst Recommendations
• Macro Economic Factors impacting India Pediatric Drugs and Vaccines Market, 2011-2021
• Vaccines Market Growth India
• India Anti-infectives Market Growth
• Kids Antihistamines Market Sales,
• Attenuated vaccines Industry Developments
• India Inactivated Vaccines Industry Size
• Toxoid Vaccines Market share
• Conjugate Vaccines Contribution India
• Vaccine Clinical Trials India
• Number of Pediatrician  Statistics
• Drug Information Dosage Side Effects
• New Drug Launches India Pharma Sector

• Key Products Covered in the Report
• Anti-infectives, Antihistamines, Cardiovascular Drugs, Live or Attenuated vaccines, Killed or Inactivated Vaccines, Toxoid Vaccines, Conjugate Vaccines, Subunit Vaccines and Recombinant Vaccines

• Companies Covered in the Report
• Sun Pharmaceuticals
• Lupin Pharmaceuticals
• Cipla
• Reddy’s Laboratories
• Abbott India
• Serum Institute of India
• Panacea Biotec
• Bharat Biotech
• GSK Pharmaceuticals
• Biological E Limited

For more information about the publication, refer to below link:
https://www.kenresearch.com/healthcare/pharmaceuticals/india-pediatric-drug-vaccine-market/81319-91.html
Related Reports:
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market
US Aesthetic Lasers and Energy Devices Market Outlook to 2020 - Aging Population and High Prevalence Rate of Obesity to Foster Future Growth
Qatar Wellness Market Outlook to 2020 - Rising Awareness about health & Fitness and Prevalence in Lifestyle Diseases will drive the Market
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Rising prevalence of chronic diseases & Inclusion of Several New Vaccines in National Immunization Programme to shape India Pediatric Drugs and Vaccines Market: Ken Research

“Launch of Anti TB drugs, introduction of IPV and several other vaccines in the national immunization programme to drive the India Pediatric Drugs and Vaccines Market”

India pediatric drugs and vaccine market has witnessed tremendous growth in the last five years largely due to high number of annual births recorded at around 25 million, launch of generic formulations of several pediatric drugs including flavored TB drugs, inclusion of several vaccines in the national immunization schedule of the country and inclining coverage of children vaccination under national immunization schedule.
Although a vast majority of the drugs sold in the country has been directed for the treatment of diseases as compared to management of the same. With rising prevalence of chronic diseases in the pediatric population of the country including diabetes and asthma, the market for drugs meant for management of diseases is deemed to incline at a faster pace in the near future.

Currently, procurement of pediatric drugs is almost entirely done through offline medium from hospital pharmacies, retail pharmacies, doctors or institutional health centers. Since the requirement of drugs is usually on an urgent basis, parents don’t prefer placing an order online and receive it a later date. However, online pharmacies have expanded at a steep pace in the last few years. Several players including the likes of Netmeds.com, 1mg, buydrug.in, Zigy, apollopharmacy.in and medidart.com have provided the much needed momentum to online retailing space. In the mid-long term, online sale of drugs is expected to witness healthy growth.
A large chunk of vaccines administered under the national immunization programme in the country are of the monovalent form. This includes monovalent oral polio vaccine, BCG, measles, Hepatitis B and Hib. Some other commonly used monovalent vaccines include rotavirus vaccine and TT. Monovalent vaccines therefore comprised for the maximum market share as of FY’2016. However, with the expected inclusion of pentavalent in the immunization programme and launch of several multivalent vaccines in the country, the market share of multivalent vaccines is expected to incline.
The market for pediatrics vaccine in India has grown at a tremendous pace in the last five years. With the introduction of new vaccines in the national immunization programme, the market is expected to perform even better in the next five years. Indian government, as per the recommendation of WHO, has included Injectable Polio Vaccine (IPV) in its Universal Immunization Program. Further, the usage of pentavalent vaccine has been expanded to all the states and union territories. India has an ambition to eliminate measles, introduce rubella (as part of Measles Rubella vaccine), rotavirus and pneumococcal vaccines in 2017 and potentially Human Papilloma Virus (HPV) vaccine and Japanese Encephalitis vaccine at a later time, impacting the total India pediatric drugs and vaccines market in a positive manner.
With expected launch of rotavirus vaccine by Serum Institute of India in FY’2017 and quadrivalent influenza vaccine by Sanofi in FY’2018 amongst other vaccines, the pediatrics vaccine market is expected to grow at a high pace. .
The report titled “India Pediatric Drugs and Vaccines Market – Rise in prevalence of chronic diseases and inclusion of several new vaccines in national immunization programme to Shape Future Growth” provides detailed overview on the pediatric drugs and vaccines market in India. This report helps readers to identify the ongoing trends in the industry and anticipated growth in future depending upon changing industry dynamics in coming years. The report is useful for investors, pharmaceutical companies, contract manufacturers, startups, and other stakeholders to align their market centric strategies according to ongoing and expected trends in the future.
For more information about the publication, refer to the below link:
https://www.kenresearch.com/healthcare/pharmaceuticals/india-pediatric-drug-vaccine-market/81319-91.html
Related Reports:
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market
US Aesthetic Lasers and Energy Devices Market Outlook to 2020 - Aging Population and High Prevalence Rate of Obesity to Foster Future Growth
Qatar Wellness Market Outlook to 2020 - Rising Awareness about health & Fitness and Prevalence in Lifestyle Diseases will drive the Market
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Life Insurance Sector Dominate Peru Insurance Industry: Ken Research

Ken Research has announced publication titled, “Life Insurance in Peru, Key Trends and Opportunities to 2020” which provides in-depth market analysis, information and insights into the Peruvian life insurance segment and a detailed outlook by product category for the Peruvian life insurance segment, and a comparison of the Peruvian insurance industry with its regional counterparts.

This report provides a comprehensive analysis of the life insurance segment in Peru and well assesses the competitive dynamics in the life insurance segment identifying the growth opportunities and market dynamics especially in key product range.

It details the key performance indicators such as written premium, incurred loss, loss ratio, commissions and expenses, total assets, total investment income and retentions during the review period and forecast period that offer a significant analysis of the key categories in the Peruvian life insurance segment, and market forecasts to 2020. It helps in comprehending the demand-side dynamics, by profiling the top life insurance companies in Peru and outlining the key regulations affecting them, key market trends, and growth opportunities in the Peruvian life insurance segment.

The life insurance segment was the largest in Peru insurance industry. Peruvian consumers favored simple, savings-oriented life insurance products with more protection choices and as a result the pension and individual life products were leading life insurance product categories particularly during 2012.

Direct marketing was one of the superior distribution channels for life products in Peru. In August 2014, the SBS made a compulsion for all independent workers under the age of 40 to contribute to the private pension system for making the need of life insurance and related policies felt.

Life insurance became the largest segment in Peruvian insurance that accounted for 47.9% of the industry's gross written premium and Insurance penetration in the life segment was 0.9% in 2015.

The Peruvian life segment was stabilized, with the 10 leading companies accounting for 99.0% of the segment's direct written premium in 2015. The opportunities for year 2020 can be predicted well, although their accuracy at the real time cannot be predicted, but for sure opportunities are guaranteed since the insurance policy related regulations are changing and improving and this segment of insurance carries a significant proportion of the insurance sector.

Key Factors Considered in the Report

Global Life insurance industry

Non-life insurance industry

Peru life insurance market research

Life insurance sector trends Peru

Peru life insurance regulations

Life insurance companies Peru

Peru Insurance Gross Written premium

For more coverage click on the link below:

https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/life-insurance-peru-key-trends-opportunities/78827-93.html

Related links:

https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/life-insurance-in-colombia-key-trends-and-opportunities-to-2019/2117-93.html

https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/life-insurance-policies-premiums-slovenia-2018-market-databook/2160-93.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249